Vincristine and intestinal pseudo-obstruction in children: report of 5 cases, literature review, and suggested management.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Etat: Public
Version: Final published version
Licence: Tous droits réservés
ID Serval
serval:BIB_17DAB5516363
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Vincristine and intestinal pseudo-obstruction in children: report of 5 cases, literature review, and suggested management.
Périodique
Journal of pediatric hematology/oncology
Auteur(s)
Diezi M., Nydegger A., Di Paolo E.R., Kuchler H., Beck-Popovic M.
ISSN
1536-3678 (Electronic)
ISSN-L
1077-4114
Statut éditorial
Publié
Date de publication
05/2010
Peer-reviewed
Oui
Volume
32
Numéro
4
Pages
e126-30
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Résumé
Intestinal pseudo-obstruction is a rare complication resulting from a variety of disorders. Symptoms include abdominal pain, nausea, vomiting, diarrhea, constipation, and malnutrition. Vincristine-related pseudo-obstruction has been reported in the literature, but its description in children and recommendations for management are lacking. A review of the literature revealed 21 reported pediatric cases of vincristine-related pseudo-obstruction. Most have, however, been attributed to a drug interaction with itraconazole, accidental vincristine overdose, or liver failure. Potential genetic causes are rarely addressed. We present here 5 cases of pseudo-obstruction related to vincristine without any identifiable predisposing factors, and a suggested algorithm for management.
Mots-clé
Adolescent, Algorithms, Antineoplastic Agents, Phytogenic/adverse effects, Child, Child, Preschool, Female, Hodgkin Disease/drug therapy, Humans, Intestinal Pseudo-Obstruction/chemically induced, Intestinal Pseudo-Obstruction/therapy, Kidney Neoplasms/drug therapy, Male, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Survival Rate, Treatment Outcome, Vincristine/adverse effects, Wilms Tumor/drug therapy
Pubmed
Web of science
Création de la notice
08/06/2010 15:09
Dernière modification de la notice
20/08/2019 12:47
Données d'usage